Recognizing First Progression in Gastric Cancers

 

Recognizing First Progression in Gastric Cancers
23:25

2nd Annual International Gastric Cancer Educational Symposium

Nutrition Care in Patients With GC: Recommendations During and After Treatment

FEATURING Rachael Lopez
  • 105 views
  • January 22, 2021
24:50

UChicago Medicine

Optimizing 2/3L Therapy for GE Adenocarcinoma: RAINBOW Paclitaxel/Ramucirumab, Margetuximab/Pembro, Recurrence Treatment Approach

FEATURING Daniel Catenacci
  • 450 views
  • February 10, 2021
  • 3
20:40

2nd Annual International Gastric Cancer Educational Symposium

Optimization of Perioperative Gastric Cancer Care: What Are the Outcomes of Neoadjuvant FLOT, Xeloda, or 5-FU/Radiation Therapy? Should We Combine FLOT With Other Agents?

FEATURING Arun Nagarajan
  • 682 views
  • February 1, 2021
  • 3
12:23

Afsaneh Barzi

RAINBOW & REGARD Trial Data on Gastric Cancer: The Impact of 2L Ramucirumab on Survival and QoL

  • 1,021 views
  • February 10, 2021
  • 3
16:00

2nd Annual International Gastric Cancer Educational Symposium

Genetic Testing in Gastric Cancer: How to Recognize Hereditary Cancer-Associated Features? How Can Genetic Test Results Impact Medical Management?

FEATURING Sara Rhode
  • 150 views
  • January 11, 2021
09:58

2020 ASCO Virtual Direct™ Highlights

Updates on Advanced GE Cancers: 2L FOLFIRI + Ramucirumab vs. Paclitaxel + Ramucirumab, T-DXd in HER2+Disease

FEATURING Daniel Catenacci
  • 383 views
  • September 16, 2020
13:08

Gastroesophageal Cancer Educational Symposium

Prevention and Detection of Gastric Cancer: How Can We Detect It Early With Blood-Based Biomarkers?

FEATURING Andrew Chan
  • 143 views
  • March 16, 2021
09:03

Geoffrey Ku

Gastric Cancer Management: Why Is It Important to Actively Treat? How to Recognize Signs of Progression?

  • 421 views
  • March 24, 2021
  • 2
05:07

Zev A. Wainberg

Efficacy Data From RAINBOW Trial on Advanced Gastric Cancer: The Effect of Adding Ramucirumab to 2L Paclitaxel on Outcomes

  • 550 views
  • March 8, 2021
  • 1
06:38

ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer

New Standard for 2nd Line Therapy in Metastatic Gastric Cancer: VEGFR2 Ramucirumab +/- Chemotherapy

FEATURING Tomislav Omrcen
  • 216 views
  • November 28, 2019
  • 1
29:08

Gastroesophageal Cancer Educational Symposium

Nutrition Considerations for Gastroesophageal Cancer: Goals, How the RD Can Help, Nutrition During Treatment, Prior and After Surgery, Myths & FAQs

FEATURING Ashley Draviam
  • 210 views
  • March 22, 2021
  • 2
22:53

2nd Annual International Gastric Cancer Educational Symposium

Managing Hereditary Diffuse Gastric Cancer: Is Prophylactic Gastrectomy Recommended for CDH1 Mutation? How to Manage LBC Risk?

FEATURING Miguel Burch
  • 182 views
  • January 11, 2021
  • 1
24:28

2nd Annual International Gastric Cancer Educational Symposium

Integrative Medicine for GC: What Is Integrative Oncology, and How to Implement It?

FEATURING Mike Cusnir
  • 299 views
  • January 11, 2021
  • 1
12:10

Shagufta Shaheen

Targeted and Novel Therapy in HER2+ Advanced Gastric Cancer: Efficacy Data on T-DXd vs. Chemotherapy, 1L Pembro / Trastuzumab / CAPEOX

  • 144 views
  • April 13, 2021
18:17

Shagufta Shaheen

2021 Update on HER2- Gastric Cancer: 1L Chemo + Nivo, Bemarituzumab + mFOLFOX6, 3L Lenvatinib + Pembro

  • 200 views
  • April 13, 2021
11:02

Moffitt Cancer Center

Utilization of ctDNA NGS Analysis in Stage IV Cancers: PANGEA Strategy for GEJ Adenocarcinoma

FEATURING Daniel Catenacci
  • 287 views
  • April 28, 2021
21:00

Raul Gonzalez

Pathologist's Perspective on Targeted Therapies in Advanced Gastric Cancer: Overview of the Most Common Biomarkers

  • 261 views
  • May 24, 2021
05:12

Bassel El-Rayes

Improving Survival in Advanced HER2+/- Gastric Cancer: Considering 2L Treatment Outcomes

  • 323 views
  • May 28, 2021
  • 3
08:35

Fox Chase Cancer Center

2L Treatment of Advanced Gastric Cancer: Moving Towards an Opportunity to Improve Survival

FEATURING Namrata Vijayvergia
  • 403 views
  • July 5, 2021
  • 2
14:38

10th Annual Winship Cancer Institute Gastrointestinal Cancer Virtual Symposium

Recent IO Data in GEJ or Gastric Cancers: Are We There Yet?

FEATURING Olatunji Alese
  • 424 views
  • July 6, 2021
09:20

2021 KUMC Virtual Multidisciplinary Oncology Review

Targeted Therapy in Advanced GE/GEJ Cancer: T-DXd, mFOLFOX6+/-1L Bemarituzumab, Margetuximab, Rucaparib+Ramucirumab+/-Nivo

FEATURING Anwaar Saeed
  • 281 views
  • June 11, 2021
  • 1
07:44

Memorial Sloan Kettering Cancer Center

ESMO 2021 Abstract Review on Genomic Landscape of Late-Stage Gastric Cancer

FEATURING Yelena Y. Janjigian
  • 196 views
  • September 23, 2021
22:59

Mayo Clinic & DDF Gastroesophageal Cancer Educational Symposium

Understanding Genetic and Environmental Risk Factors in Gastroesophageal Cancers

FEATURING Lisa Boardman
  • 81 views
  • September 22, 2021
08:20

Massachusetts General Hospital Cancer Center

ESMO 2021 Updates on 1L DKN-01 + Tislelizumab & Chemotherapy in Advanced GEA: DisTinGuish Trial

FEATURING Samuel Klempner
  • 100 views
  • October 13, 2021